The number of people having joint replacement surgeries has increased, which has fueled demand for osseointegration implants worldwide. For instance, the National Center for Biotechnology Information reported in June 2019 that approximately 40 percent of the world's population over 55 suffers from chronic knee pain, of which 50.8 million experience pain that is incapacitating, and that each year, about 2.6 million people undergo knee replacement surgery. A hip replacement affects about 0.8 percent of Americans, whereas a knee replacement affects 1.5 percent. Compared to males, more women than men live with prosthetic knees and hips. With a total population of 755 million people in 18 countries, there are an estimated 1,324,000 primary and revision total knee surgeries performed each year. Over 992,090 primary total hip replacements, 1,087,611 knee replacements, 4,687 ankle replacements, 30,720 shoulder replacements, and 2,872 elbow replacements were carried out in the UK in 2017, according to the National Joint Registry (NJR). Also, according to the National Spinal Cord Injury Statistics Center, there were approximately 17,500 new cases of spinal cord injury (SCI) in the United States per year, and 285,000 people were projected to have SCI in 2017. (NSCISC).
The market for Osseointegration Implants is anticipated to reach a value of US$ 7,558.90 million in 2022 and grow at a CAGR of 6.3% from 2022 to 2030.
Major players in the Osseointegration Implants Industry:
1)DENTSPLY Sirona:
A manufacturer and distributor of dental tools and supplies on a global scale is Dentsply Sirona Inc. Headquarter location: Charlotte, North Carolina, USA. created in 1899. Propel Orthodontics, a market leader in the development of orthodontic devices, sold its assets to Dentsply Sirona.
2)Danaher Corporation:
The founders of Danaher converted a real estate company into a manufacturing business with an industrial focus in 1984. Danaher today largely concentrates on producing scientific instruments and consumables in three segments: diagnostics, Life sciences, and environmental and applied solutions, as a result of a number of mergers, acquisitions, and divestitures. The business revealed plans to sell its environmental and applied solutions division in 2023, allowing it to only concentrate on the life sciences and diagnostics. Headquarters in the United States, in Washington, D.C.